{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:55:36Z","timestamp":1790438136962,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.lpm.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T22:38:31Z","timestamp":1540852711000},"page":"872-877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["R\u00e8gles de bon usage des benzodiaz\u00e9pines"],"prefix":"10.1016","volume":"47","author":[{"given":"Alexis","family":"Revet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Yrondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lpm.2018.10.008_bib0120","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00228-016-2044-y","article-title":"Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users","volume":"72","author":"Benard-Laribiere","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.lpm.2018.10.008_bib0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pds.4123","article-title":"Trends in incident use of benzodiazepines and Z-drugs in France from 2006\u00a0to 2012: a population-based study","volume":"26","author":"Benard-Laribiere","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.lpm.2018.10.008_bib0130","series-title":"Rang & Dale's Pharmacology","author":"Ritter","year":"2015"},{"issue":"24","key":"10.1016\/j.lpm.2018.10.008_bib0135","first-page":"2399","article-title":"Treatment of benzodiazepine dependence","volume":"376","author":"Soyka","year":"2017","journal-title":"N Engl J of Med"},{"key":"10.1016\/j.lpm.2018.10.008_bib0140","series-title":"Pharmacologie des substances addictives\u00a0: les points essentiels","author":"College national de pharmacologie medicale","year":"2018"},{"key":"10.1016\/j.lpm.2018.10.008_bib0145","unstructured":"LegiFrance. D\u00e9cret no 99-249\u00a0du 31\u00a0mars 1999\u00a0relatif aux substances v\u00e9n\u00e9neuses et \u00e0 l\u2019organisation de l\u2019\u00e9valuation de la pharmacod\u00e9pendance, modifiant le code de la sant\u00e9 publique 1999 [Available from: https:\/\/www.legifrance.gouv.fr\/affichTexte.do?.cidTexte=JORFTEXT000000393106&categorieLien=id"},{"issue":"415","key":"10.1016\/j.lpm.2018.10.008_bib0150","first-page":"356","volume":"38","author":"Quelques \u00e9l\u00e9ments pour le choix d\u2019une benzodiaz\u00e9pine dans les plaintes de mauvais sommeil","year":"2018","journal-title":"Rev Prescrire"},{"key":"10.1016\/j.lpm.2018.10.008_bib0155","series-title":"Substance(s)\u00a0: benzodiaz\u00e9pines ou apparent\u00e9s. Guide interactions m\u00e9dicamenteuses","author":"Revue Prescrire","year":"2018"},{"issue":"3","key":"10.1016\/j.lpm.2018.10.008_bib0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.therap.2015.11.004","article-title":"Benzodiazepine or non-benzodiazepine hypnotics withdrawal syndrome during hospitalization: a series of 22\u00a0cases","volume":"71","author":"Thorel","year":"2016","journal-title":"Therapie"},{"issue":"140","key":"10.1016\/j.lpm.2018.10.008_bib0165","first-page":"192","article-title":"Prescribe, but also know how to \u201cdeprescribe\u201d","volume":"22","author":"Montastruc","year":"2013","journal-title":"Prescrire Int"},{"key":"10.1016\/j.lpm.2018.10.008_bib0170","unstructured":"Agence Nationale de securite du medicament et des produits de sante. Plan d\u2019actions de l\u2019ANSM visant \u00e0 r\u00e9duire le m\u00e9susage des benzodiaz\u00e9pines 2012 [Available from: http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Plan-d-actions-de-l-ANSM-visant-a-reduire-le-mesusage-des-benzodiazepines-Point-d-information"},{"key":"10.1016\/j.lpm.2018.10.008_bib0175","unstructured":"Agence Nationale de securite du medicament et des produits de ANSM sante. Rivotril (clonaz\u00e9pam)\u00a0: Modification des conditions de prescription et de d\u00e9livrance 2012 [Available from: http:\/\/ansm.sante.fr\/S-informer\/Informations-de-securite-Lettres-aux-professionnels-de-sante\/Rivotril-clonazepam-Modification-des-conditions-de-prescription-et-de-delivrance-Lettre-aux-professionnels-de-sante-Actualise-le-04-01-2012"},{"issue":"8","key":"10.1016\/j.lpm.2018.10.008_bib0180","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","article-title":"The relationship between benzodiazepine use and traffic accidents: A systematic literature review","volume":"24","author":"Smink","year":"2010","journal-title":"CNS drugs"},{"issue":"4","key":"10.1016\/j.lpm.2018.10.008_bib0185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.2011.3","article-title":"Benzodiazepine-like hypnotics and the associated risk of road traffic accidents","volume":"89","author":"Orriols","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lpm.2018.10.008_bib0190","series-title":"R\u00e9seau fran\u00e7ais des centres r\u00e9gionaux de pharmacovigilance","year":"2018"},{"issue":"2","key":"10.1016\/j.lpm.2018.10.008_bib0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.therap.2016.02.012","article-title":"Pharmacovigilance, risks and adverse effects of self-medication","volume":"71","author":"Montastruc","year":"2016","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.lpm.2018.10.008_bib0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/0976-500X.189680","article-title":"Deprescription: the prescription metabolism","volume":"7","author":"Sivagnanam","year":"2016","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.lpm.2018.10.008_bib0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-015-0019-8","article-title":"Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review","volume":"16","author":"Pollmann","year":"2015","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.lpm.2018.10.008_bib0210","series-title":"Benzodiazepine and z-drug withdrawal","author":"NICE","year":"2013"},{"key":"10.1016\/j.lpm.2018.10.008_bib0215","unstructured":"H.A.S.HAdS. Arr\u00eat des benzodiaz\u00e9pines et m\u00e9dicaments apparent\u00e9s\u00a0: d\u00e9marche du m\u00e9decin traitant en ambulatoire 2015 [Available from: https:\/\/www.has-sante.fr\/portail\/jcms\/c_2038262\/fr\/arret-des-benzodiazepines-et-medicaments-apparentes-demarche-du-medecin-traitant-en-ambulatoire"},{"issue":"292","key":"10.1016\/j.lpm.2018.10.008_bib0220","first-page":"115","volume":"28","author":"R\u00e9ussir l\u2019arr\u00eat d\u2019une benzodiaz\u00e9pine","year":"2018","journal-title":"Rev Prescrire"},{"issue":"5","key":"10.1016\/j.lpm.2018.10.008_bib0225","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline","volume":"64","author":"Pottie","year":"2018","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.lpm.2018.10.008_bib0115","series-title":"Qu\u2019est-ce que la d\u00e9prescription\u00a0?","author":"Deprescribing.org","year":"2018"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218303865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218303865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T21:09:43Z","timestamp":1543439383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498218303865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0755498218303865"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2018.10.008","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e8gles de bon usage des benzodiaz\u00e9pines","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}